← Back to Search

Nurse-Led Education for Advanced Cancer

N/A
Waitlist Available
Led By Anne Reb
Research Sponsored by City of Hope Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 10 weeks
Awards & highlights

Study Summary

This trial looks at a nurse-led program to help patients with worries, fears, and uncertainty. It will help researchers understand if the program is helpful and practical. This study may help patients learn more effective ways to cope.

Who is the study for?
This trial is for English-speaking patients with stage III or IV lung or gynecologic cancer, who have been diagnosed at least 3 months ago and are experiencing significant fear about their cancer progressing, as shown by a score of 34 or higher on a specific questionnaire. It's not suitable for those in hospice care or with severe mental illnesses like psychosis.Check my eligibility
What is being tested?
The study tests an educational program led by nurses aimed at helping advanced cancer patients manage their fears and uncertainties about the future. The goal is to see if this approach can improve coping strategies and whether it's feasible in medical centers and community clinics.See study design
What are the potential side effects?
Since this intervention involves education rather than medication, traditional physical side effects are not expected. However, discussing fears and concerns may bring up emotional discomfort temporarily.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 10 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 10 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability
Feasibility of recruitment
Feasibility of the intervention
Other outcome measures
Anxiety
Cancer-specific distress
Depression
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Supportive care (videoconference, questionnaire, survey)Experimental Treatment1 Intervention
Patients participate in 5 videoconference sessions over 30 minutes each over 6 weeks focused on worry management skills, values-based goal setting, and brief mindfulness-based practices, then complete patient workbook activities after each session over 15-20 minutes per day. Patients also complete a survey over 8 minutes at 6 weeks, an exit interview at 7 weeks, and questionnaires over 25 minutes each at baseline, 6 weeks, and 10 weeks.

Find a Location

Who is running the clinical trial?

City of Hope Medical CenterLead Sponsor
565 Previous Clinical Trials
1,921,418 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,654 Previous Clinical Trials
40,933,111 Total Patients Enrolled
Anne RebPrincipal InvestigatorCity of Hope Medical Center
1 Previous Clinical Trials
75 Total Patients Enrolled

Media Library

Nurse-Led Intervention Clinical Trial Eligibility Overview. Trial Name: NCT04819997 — N/A
Lung Cancer Research Study Groups: Supportive care (videoconference, questionnaire, survey)
Lung Cancer Clinical Trial 2023: Nurse-Led Intervention Highlights & Side Effects. Trial Name: NCT04819997 — N/A
Nurse-Led Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT04819997 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still slots available for participants in this medical experiment?

"As reflected on clinicaltrials.gov, this trial is not currently enlisting new candidates. The study was initially posted in March 2021 and the information was last refreshed in June 2022. However, there are still 1,541 other studies actively recruiting patients as of now."

Answered by AI
~7 spots leftby Dec 2024